CancerVax Reports Nanoparticle Component Success in Preparation for Animal Studies
Lehi, Utah, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Lehi, Utah, December 17, 2025 – CancerVax, Inc., the developer of a breakthrough universal cancer treatment platform that uses the body’s immune system to treat cancer, today announced that recent in-vitro …